赵美娜, 郭永正, 毛学超, 李国华, 李嘉, 王智伟, 奚苗苗. 人参皂苷素Rb1通过减轻氧化应激改善大鼠机械创伤诱发的迟发性心脏功能下降[J]. 心脏杂志, 2018, 30(6): 626-630,641. DOI: 10.13191/j.chj.2018.0150
    引用本文: 赵美娜, 郭永正, 毛学超, 李国华, 李嘉, 王智伟, 奚苗苗. 人参皂苷素Rb1通过减轻氧化应激改善大鼠机械创伤诱发的迟发性心脏功能下降[J]. 心脏杂志, 2018, 30(6): 626-630,641. DOI: 10.13191/j.chj.2018.0150
    ZHAO Mei-na, GUO Yong-zheng, MAO Xue-chao, LI Guo-hua, LI Jia, WANG Zhi-wei, XI Miao-miao. Ginsenoside Rb1 reduces oxidative stress and improves cardiac dysfunction induced by mechanical trauma in rats[J]. Chinese Heart Journal, 2018, 30(6): 626-630,641. DOI: 10.13191/j.chj.2018.0150
    Citation: ZHAO Mei-na, GUO Yong-zheng, MAO Xue-chao, LI Guo-hua, LI Jia, WANG Zhi-wei, XI Miao-miao. Ginsenoside Rb1 reduces oxidative stress and improves cardiac dysfunction induced by mechanical trauma in rats[J]. Chinese Heart Journal, 2018, 30(6): 626-630,641. DOI: 10.13191/j.chj.2018.0150

    人参皂苷素Rb1通过减轻氧化应激改善大鼠机械创伤诱发的迟发性心脏功能下降

    Ginsenoside Rb1 reduces oxidative stress and improves cardiac dysfunction induced by mechanical trauma in rats

    • 摘要: 目的 探讨人参皂苷素Rb1(GRb1)对大鼠机械创伤(MT)所致的迟发性心脏功能下降的保护作用。 方法 利用Nobel-Collip创伤仪制备大鼠MT模型,将大鼠随机分为假手术组(Sham)、创伤模型(MT+Vehicle,MT+V)组、创伤GRb1治疗(MT+GRb1)组,检测各组心脏功能、超氧化物歧化酶(SOD)以及丙二醛(MDA)含量的变化;分离培养大鼠乳鼠心肌细胞,将心肌细胞与各组大鼠血清孵育24 h并给予GRb1或超氧阴离子清除剂(TEMPOL)处理,分为对照(SS)组、创伤血清(TS)组、创伤血清+GRb1处理(TS+GRb1)组、创伤血清+TEMPOL处理(TS+TEMPOL)组,检测细胞存活率以及活性氧(ROS)、乳酸脱氢酶(LDH)和MDA含量的变化。 结果 与Sham组相比,MT后2 h大鼠心肌组织中SOD活性显著下降(P<0.01)、MDA水平升高(P<0.01);MT后24 h心脏功能明显受损,表现为LVDP、±dP/dtmax均显著下降(P<0.01)。给予GRb1治疗可增强心肌组织中SOD活性(P<0.01)、降低MDA水平(P<0.01),进而改善心脏功能(P<0.05)。对于离体分离培养的大鼠心肌细胞,创伤大鼠血清处理24 h显著增加细胞内ROS和MDA的含量(P<0.01);利用TEMPOL或者GRb1处理均可减轻(P<0.05)创伤大鼠血清诱导的氧化应激并促进心肌细胞存活。 结论 GRb1通过减轻MT早期诱发的心肌细胞氧化应激保护心肌细胞,进而改善MT导致的迟发性心脏功能下降。

       

      Abstract: AIM To explore whether Ginsenoside Rb1 (GRb1) improves cardiac dysfunction induced by mechanical trauma (MT) in rats and the underlying mechanisms. METHODS Anesthetized rats were subjected to 200 revolutions at a rate of 30 rpm in Noble-Collip drum to induce a nonlethal mechanical trauma and the rats were randomized to receive vehicle or GRb1. An in vitro study was performed on cultured cardiomyocytes subjected to sham-traumatic serum (SS), traumatic serum (TS), traumatic serum and Ginsenoside Rb1(TS+GRb1) or traumatic serum and TEMPOL (TS+TEMPOL). RESULTS Cardiac superoxide dismutase SOD (P<0.01) levels dropped and malondialdehyde MDA (P<0.01) production was significantly elevated at 2hr after MT, which led to diminished cardiac function at 24 hr after MT, as evidenced by decreased LVDP and±dP/dtmax (P<0.01). GRb1 treatment significantly reduced ROS production and improved cardiac dysfunction after MT (P<0.05). Incubation of cardiomyocytes with TS significantly increased reactive oxygen species ROS and MDA generation (P<0.01). Treatment with GRb1 or ROS scavenger TEMPOL reduced oxidative stress induced by TS and increased cell viability (P<0.05). CONCLUSION GRb1 treatment alleviates oxidative stress induced by MT at an early stage, which reduces secondary cardiac injury and improves cardiac dysfunction after MT.

       

    /

    返回文章
    返回